查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1520495

2024-2032 年按设备类型、应用（冠状动脉疾病、心律不整、心臟衰竭等）、最终用户和地区分類的心血管设备市场报告

Cardiovascular Devices Market Report by Device Type, Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, and Others), End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球心血管器材市场规模达589亿美元。介入性心臟病学手术的引入，加上有利的报销政策，正在刺激市场成长。

心血管器材市场分析：

主要市场驱动力：心臟衰竭、冠状动脉疾病、心律不整等心血管疾病的数量不断增加，正在推动市场发展。此外，消费者越来越倾向于采用微创取代传统心臟直视手术，以加速復健速度、减少住院时间、提高病患舒适度等，这也是另一个重要的成长诱导因素。

主要市场趋势：3D 列印和人工智慧 (AI) 技术的不断进步导致先进心血管设备的推出，以提供更高的精度和安全性，这是刺激整个市场的新兴趋势之一。

地理趋势：发达的医疗基础设施正在支撑北美市场。除此之外，主要医疗器材製造商的存在以及研发活动投资的增加进一步对区域市场产生正面影响。

竞争格局：根据心血管设备市场概况，全球市场上的一些知名公司包括雅培实验室、B. Braun Melsungen AG、百多力、波士顿科学公司、佳能医疗系统公司、康德乐健康公司、爱德华生命科学公司、通用电气公司、LivaNova PLC、美敦力 PLC、西门子 Healthineers GmbH (Siemens AG) 和泰尔茂心血管系统公司 (Terumo Corporation) 等。

挑战与机会：心血管设备的推出涉及复杂的工程和先进材料的集成，这可能会阻碍市场的成长。然而，关键参与者正在确保这些设备（尤其是植入式设备）的长期可靠性和安全性。反过来，这将在未来几年继续扩大全球市场。

心血管设备市场趋势：

对微创手术的需求

人们的偏好从传统的心臟直视手术转向侵入性较小的方法，以最大限度地缩短恢復时间、降低手术风险、改善患者的治疗效果等，这正在刺激市场。例如，2024 年 4 月，由戈尔韦大学研究小组监督的 FAST TRACK CABG 研究首次测试了一种为患者规划、指导和进行心臟搭桥手术的新方法。它证明了基于人工智慧的血流扫描的非侵入性心臟CT是可行且安全的。除此之外，机器人技术和即时成像技术的广泛采用有助于准确放置瓣膜、支架和其他设备，而无需大切口，这也提高了心血管设备市场收入。例如，2024 年 2 月，飞利浦推出了 LumiGuide，它采用光纤 RealShape (FORS) 技术，用于无辐射、微创手术。除此之外，微创手术是使用专门的心血管仪器和先进的成像技术透过小切口进行的，从而可以进行有针对性的精确治疗。一些常见的例子包括经导管二尖瓣修復术 (TMVR)、经导管主动脉瓣置换术 (TAVR)、内视镜静脉采集等。例如，2022 年12 月，全球领先的医疗保健公司之一雅培(Abbott) 宣布推出新型经导管主动脉瓣植入(TAVI) 系统Navitor，适用于印度患有严重主动脉瓣狭窄且手术风险极高或极高的患者。随着技术的进步，这些手术变得更加有效和安全，从而越来越多地采用它们来治疗多种心血管疾病。例如，2024 年 5 月，根据心血管造影和介入学会 (SCAI) 年会上公布的一年新资料，Anteris Technologies 开发的新型仿生经导管主动脉瓣置换术 (TAVR) 系统可以为心臟科医生提供治疗严重主动脉瓣狭窄（AS）的新方法。

引入增强型变异体

心血管设备在慢性心臟病和中风的治疗、诊断和管理中发挥着至关重要的作用。因此，主要参与者正在推出新颖的设备，使医疗保健专业人员能够准确评估心血管疾病的严重程度、监测患者的心臟健康状况、改进有效的治疗方法等。患者数量正在不断增加智慧支架、植入式心律调节器、除颤器等的普及，这反过来又对心血管设备市场前景产生正面影响。例如，2023年12月，Terumo India宣布推出Ultimaster Nagomi，这是一种药物洗脱支架，旨在用于治疗冠状动脉疾病。除此之外，为引进改良的心血管设备（包括心律调节器）而对研发活动的投资不断增加，也是重要的成长诱导因素。例如，2023年5月，心律管理领域的全球开发商之一微创公司的多种植入式心律调节器Alizea和Celea获得FDA批准。此外，它们还具有 AutoMRI 模式，这是 MicroPort 发明的演算法，可提高接受 MRI 检查的患者的安全性。同样，2023 年 7 月，雅培宣布 FDA 批准其无引线心律调节器系统 Aveir DR。此外，机器学习和人工智慧用于分析大量心血管资料，以个性化治疗计划、预测患者结果、提高诊断准确性等。美国梅奥诊所表示，具有人工智慧功能的数位听诊器可以改善围产期心肌病变的诊断，围产期心肌病变是一种可能危及生命的疾病，会削弱女性在怀孕期间的心肌功能。

策略伙伴关係

知名公司、医疗器材製造商、研究机构和医疗保健组织正在合作并进行併购活动，以引进心血管设备，包括精确成像工具。这是心血管设备市场近期的机会之一。例如，2023 年 9 月，领先的心臟资料管理平台之一 PaceMate 宣布与 MedAxiom 合作，在单一云端原生环境中为心臟和 EHR资料创建工作流程解决方案。据此，2023年10月，GE医疗保健与波士顿科学公司合作开发增强型心臟影像系统。此外，这些合作伙伴关係还可以帮助公司应对复杂的监管环境，并利用合作伙伴的当地专业知识和已建立的分销网络进入国际市场。例如，2023 年 6 月，飞利浦与 Biotronik 建立合作伙伴关係，扩大飞利浦 SymphonySuite 客户可用的心血管设备范围。除此之外，2023 年 5 月，PaceMate 与 AliveCor 合作，AliveCor 是 FDA 批准的个人心电图技术和远端病患管理解决方案的全球领导者之一，涵盖植入式心臟装置。

心血管器材市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的心血管器材市场预测。我们的报告根据设备类型、应用程式和最终用户对市场进行了分类。

依设备类型细分：

诊断和监测设备

心电图（ECG）

远端心臟监测

其他的

治疗及手术设备

心律管理 (CRM) 设备

导管

支架

心臟瓣膜

其他的

治疗和手术设备是最受欢迎的设备类型

该报告根据设备类型对市场进行了详细的细分和分析。这包括诊断和监测设备（心电图 (ECG) 远端心臟监测等）以及治疗和手术设备（心律管理 (CRM) 设备、导管、支架、心臟瓣膜等）。根据该报告，治疗和手术设备占最大的部分。

旨在治疗心血管疾病的外科手术和治疗干预措施的数量不断增加正在推动该领域的成长。此外，治疗和手术设备包括植入式心臟復律去颤器（ICD）、支架、心律调节器、导管、心臟瓣膜、心室辅助装置（VAD）等。提供机械循环支持等。例如，2023 年 12 月，全球医疗保健技术领导者之一美敦力公司 (Medtronic plc) 宣布 FDA 批准 PulseSelect 脉衝场消融 (PFA) 系统用于治疗阵发性和持续性心房颤动 (AF)。与此一致，2023年6月，Magenta Medical启动了一项世界上最小的心臟帮浦的可行性研究，可减少心臟手术期间的血管通路併发症。

按应用划分：

冠状动脉疾病 (CAD)

心律不整

心臟衰竭

其他的

冠状动脉疾病（CAD）主导心血管设备市场份额

该报告根据应用程式提供了详细的市场细分和分析。这包括冠状动脉疾病（CAD）、心律不整、心臟衰竭等。根据该报告，冠状动脉疾病（CAD）代表了最大的市场区隔。

用于治疗、诊断和管理冠状动脉疾病的 CAD 设备正在各国广泛关注。此外，诊断设备的广泛采用，如血管内超音波 (IVUS) 设备、血管摄影系统和电脑断层血管摄影 (CTA) 机，有助于评估冠状动脉阻塞的严重程度，正在推动市场发展。例如，2022年8月，美敦力宣布在获得CE标誌批准后推出其新型药物洗脱冠状动脉支架Onyx Frontier药物洗脱支架（DES）。除此之外，2024 年 1 月，致力于创建心臟病诊断新护理标准的公司之一 Cleerly 推出了 Cleerly ISCHEMIA，该产品最近获得了美国食品和药物管理局 (FDA) 510(k) 医疗器械许可。 Cleerly ISCHEMIA 分析软体是一种基于机器学习的自动化决策支援工具，专为接受冠状动脉电脑断层血管摄影 (CCTA) 的患者而设计。

按最终用户划分：

医院

专科诊所

其他的

医院占据整体市场份额的大部分

该报告提供了基于最终用户的详细市场细分和分析。这包括医院、专科诊所等。报告称，医院占最大部分。

医院是心血管设备的主要最终使用者。他们提供广泛的心臟服务，例如心血管疾病的治疗、诊断和外科手术。医院拥有心导管实验室和专门的心臟科，配备先进的影像系统和手术室，这提高了心血管设备市场的近期价格。例如，2024 年 1 月，安大略省卫生部长西尔维亚琼斯宣布在加拿大基奇纳的圣玛丽总医院建立一个新的心臟实验室，以帮助心臟病患者。他们需要一系列全面的设备，例如植入设备、诊断设备、手术器械、监测系统等，这正在推动这一细分市场的成长。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美在市场上表现出明显的主导地位

市场研究报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是心血管设备最大的市场。

包括中风和周边动脉疾病在内的心血管疾病的盛行率不断上升，正在推动该区域市场的发展。例如，根据加拿大心臟和中风基金会2022年2月发布的报告，有75万名患者被诊断出心臟衰竭。此外，有利的报销政策和快速的监管批准也是重要的成长诱导因素。例如，2023 年 9 月，CorVista Health 宣布 FDA 批准其用于检测心臟病是否存在的非侵入性医疗设备系统。与此一致，2024年1月，专注于结构性心臟病的瑞典医疗器材公司Occlutech的ASD封堵器获得美国FDA批准，用于治疗心房中隔缺损（ASD）。除此之外，根据心血管设备市场统计，无线心电图的引入可以实现即时患者监测和诊断。反过来，这将在未来几年继续刺激区域市场。例如，2021年2月，VivaLNK开发了一款穿戴式心电图监测解决方案，旨在在六分钟步行测试（6MWT）期间无线捕捉心电图和心率。

竞争格局：

主要参与者正在大力投资研发，以开发创新的心血管设备。他们专注于提高设备性能、耐用性和患者治疗效果。研发工作旨在引进先进技术，例如微创手术、远端监控系统和个人化医疗方法。此外，心血管设备市场公司不断推出新的心血管设备以扩大其产品组合。这些发布通常涉及具有改进功能和增强功能的下一代设备。他们优先考虑解决未满足的临床需求，例如针对特定心血管疾病的新疗法或提供更高精度和易用性的设备。除此之外，主要参与者、医疗保健提供者和研究机构之间的合作和伙伴关係在心血管设备市场上很常见。这些合作促进创新，促进知识交流，并利用集体专业知识和资源来开发新技术和解决方案并将其商业化。

市场研究报告对竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

雅培实验室

贝朗梅尔松根股份公司

百多力

波士顿科学公司

佳能医疗系统公司

康德乐健康公司

爱德华兹生命科学公司

通用电气公司

利瓦诺瓦公司

美敦力公司

西门子医疗有限公司 (Siemens AG)

泰尔茂心血管系统株式会社（泰尔茂株式会社）

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

心血管器材市场最新动态：

2024 年 5 月：根据心血管造影与介入学会 (SCAI) 年会上公布的一年新资料，Anteris Technologies 开发的新型仿生经导管主动脉瓣置换术(TAVR) 系统可以为心臟科医生提供一种新方法治疗严重主动脉瓣狭窄（AS）。

2024 年 5 月：根据《npj Fexible Electronics》杂誌上发表的文章，来自中国的研究团队提出了一种使用穿戴式感测器评估血管年龄和心血管疾病的新方法。

2024 年 4 月：由戈尔韦大学研究小组监督的 FAST TRACK CABG 研究首次测试了一种为患者规划、指导和进行心臟搭桥手术的新方法。

2024 年1 月：印度美敦力私人有限公司(India Medtronic Private Limited) 宣布与Cardiac Design Labs (CDL) 进行策略合作，以扩大、推出和扩大对CDL 的新型诊断技术Padma Rhythms 的使用，Padma Rhythms 是一种外部循环记录器(ELR) 贴片，专为长期和慢性疾病而设计。

本报告回答的关键问题

  • 2023年全球心血管器材市场规模是多少
  • 2024-2032年全球心血管器材市场的预期成长率是多少
  • COVID-19 对全球心血管器材市场有何影响
  • 推动全球心血管器材市场的关键因素是什么
  • 根据设备类型，全球心血管设备市场的细分如何
  • 基于应用的全球心血管器材市场的细分如何
  • 基于最终用户的全球心血管器械市场的细分情况如何
  • 全球心血管器材市场的重点区域有哪些
  • 谁是全球心血管设备市场的主要参与者/公司

本报告回答的关键问题

  • 2023年全球心血管器材市场规模有多大？
  • 2024-2032年全球心血管器材市场的预期成长率是多少？
  • COVID-19 对全球心血管器材市场有何影响？
  • 推动全球心血管器材市场的关键因素是什么？
  • 根据设备类型，全球心血管设备市场的细分如何？
  • 基于应用的全球心血管器械市场的细分情况如何？
  • 基于最终用户的全球心血管设备市场的细分情况如何？
  • 全球心血管器材市场的重点区域有哪些？
  • 谁是全球心血管设备市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球心血管器材市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依设备类型

  • 诊断和监测设备
    • 市场走向
    • 关键环节
      • 心电图（ECG）
      • 远端心臟监测
      • 其他的
    • 市场预测
  • 治疗及手术设备
    • 市场走向
    • 关键环节
      • 心律管理 (CRM) 设备
      • 导管
      • 支架
      • 心臟瓣膜
      • 其他的
    • 市场预测

第 7 章：市场区隔：按应用

  • 冠状动脉疾病 (CAD)
    • 市场走向
    • 市场预测
  • 心律不整
    • 市场走向
    • 市场预测
  • 心臟衰竭
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 专科诊所
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik
    • Boston Scientific Corporation
    • Canon Medical Systems Corporation
    • Cardinal Health Inc.
    • Edwards Lifesciences Corporation
    • General Electric Company
    • LivaNova PLC
    • Medtronic PLC
    • Siemens Healthineers GmbH (Siemens AG)
    • Terumo Cardiovascular Systems Corporation (Terumo Corporation)
Product Code: SR112024A5240

The global cardiovascular devices market size reached US$ 58.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 98.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032. The introduction of interventional cardiology procedures, coupled with favorable reimbursement policies, are stimulating the market growth.

Cardiovascular Devices Market Analysis:

Major Market Drivers: The increasing number of cardiovascular conditions, such as heart failure, coronary artery disease, arrhythmias, etc., is propelling the market. Moreover, the rising consumer inclination towards minimally invasive alternatives to traditional open-heart surgeries for faster recovery, reduced hospital stays, improved patient comfort, etc., is also acting as another significant growth-inducing factor.

Key Market Trends: The growing advancements in 3D printing and artificial intelligence (AI) technologies that are leading to the launch of advanced cardiovascular devices to offer enhanced precision and safety are among the emerging trends stimulating the overall market.

Geographical Trends: The well-developed healthcare infrastructures are bolstering the market in North America. Apart from this, the presence of major medical device manufacturers and the elevating investments in R&D activities are further positively influencing the regional market.

Competitive Landscape: According to the cardiovascular devices market overview, some of the prominent companies across the global market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, LivaNova PLC, Medtronic PLC, Siemens Healthineers GmbH (Siemens AG), and Terumo Cardiovascular Systems Corporation (Terumo Corporation), among many others.

Challenges and Opportunities: The launch of cardiovascular devices involves complex engineering and integration of advanced materials, which can hamper the market growth. However, key players are ensuring the long-term reliability and safety of these devices, particularly those that are implantable. This, in turn, will continue to augment the global market in the coming years.

Cardiovascular Devices Market Trends:

Demand for Minimally Invasive Procedures

The shifting preferences of individuals from traditional open-heart surgeries toward less invasive methodologies that minimize recovery times, reduce surgical risks, improve patient outcomes, etc., are stimulating the market. For example, in April 2024, the FAST TRACK CABG study, overseen by a team of researchers at the University of Galway, tested a new approach to the planning, guidance, and conducting of heart bypass surgery on patients for the first time. It demonstrated that non-invasive cardiac CT with AI-powered blood flow scanning is feasible and safe. Besides this, the widespread adoption of robotics and real-time imaging techniques facilitates the accurate placement of valves, stents, and other devices without the need for large incisions, which is also elevating the cardiovascular devices market revenue. For instance, in February 2024, Philips introduced LumiGuide, which is powered by Fiber Optic RealShape (FORS) technology, for radiation-free, minimally invasive surgeries. Apart from this, minimally invasive procedures are performed via small incisions using specialized cardiovascular instruments and advanced imaging techniques, which allow for targeted and precise treatments. Some of the common examples include transcatheter mitral valve repair (TMVR), transcatheter aortic valve replacement (TAVR), endoscopic vein harvesting, etc. Consequently, they are gaining traction across the globe. For example, in December 2022, Abbott, one of the leading global healthcare companies, announced the launch of its novel transcatheter aortic valve implantation (TAVI) system, Navitor, for individuals in India with severe aortic stenosis who are at high or extreme surgical risk. As technology advances, these procedures are becoming more effective and safer, thereby leading to their increasing adoption in treating numerous cardiovascular conditions. For instance, in May 2024, according to new one-year data presented at the annual meeting of the Society for Cardiovascular Angiography and Interventions (SCAI), a new biomimetic transcatheter aortic valve replacement (TAVR) system developed by Anteris Technologies can offer cardiologists with a new way to treat severe aortic stenosis (AS).

Introduction of Enhanced Variants

Cardiovascular devices play a crucial role in the treatment, diagnosis, and management of chronic heart conditions and stroke. Consequently, key players are launching novel devices that enable healthcare professionals to accurately assess the severity of cardiovascular diseases, monitor the heart health of patients, improve effective therapies, etc. Moreover, the increasing number of patients requiring intervention to address their cardiovascular conditions is escalating the popularity of smart stents, implantable pacemakers, defibrillators, etc. This, in turn, is positively influencing the cardiovascular devices market outlook. For example, in December 2023, Terumo India announced the launch of Ultimaster Nagomi, a drug-eluting stent intended for use in the treatment of coronary artery disease. Besides this, the growing investments in R&D activities to introduce improved cardiovascular devices, including pacemakers, are acting as significant growth-inducing factors. For instance, in May 2023, MicroPort, one of the global developers in the field of cardiac rhythm management, received FDA approval for its wide range of implantable pacemakers, Alizea and Celea. Additionally, they feature AutoMRI mode, an algorithm invented by MicroPort, that increases the safety of patients who are undergoing an MRI examination. Similarly, in July 2023, Abbott announced the FDA approval of its leadless pacemaker system, Aveir DR. Furthermore, machine learning and AI are employed for analyzing vast amounts of cardiovascular data to personalize treatment plans, predict patient outcomes, improve diagnostic accuracies, etc. For example, in January 2024, research led by Dr. Demilade Adedinsewo, one of the cardiologists at the Mayo Clinic in the U.S., suggested that the AI-enabled digital stethoscope could improve the diagnosis of peripartum cardiomyopathy, a potentially life-threatening condition that weakens the heart muscle of women during pregnancy.

Strategic Partnerships

Prominent companies, medical device manufacturers, research institutions, and healthcare organizations are collaborating and entering into mergers and acquisitions activities to introduce cardiovascular devices, including precise imaging tools. This represents one of the cardiovascular devices market recent opportunities. For instance, in September 2023, PaceMate, one of the leading cardiac data management platforms, announced the partnership with MedAxiom to create workflow solutions for cardiac and EHR data in a single, cloud-native environment. In line with this, in October 2023, GE HealthCare collaborated with Boston Scientific to develop enhanced cardiac imaging systems. Additionally, these partnerships aid companies in navigating complex regulatory landscapes and gaining access to international markets by leveraging the local expertise and established distribution networks of their partners. For example, in June 2023, Philips entered into a partnership with Biotronik to expand the range of cardiovascular devices available for Philips SymphonySuite customers. Besides this, in May 2023, PaceMate collaborated with AliveCor, one of the global leaders in FDA-cleared personal electrocardiogram technology and remote patient management solutions, to encompass implantable cardiac devices.

Cardiovascular Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with the cardiovascular devices market forecast at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the device type, application, and end user.

Breakup by Device Type:

Diagnostic and Monitoring Devices

Electrocardiogram (ECG)

Remote Cardiac Monitoring

Others

Therapeutic and Surgical Devices

Cardiac Rhythm Management (CRM) Devices

Catheter

Stents

Heart Valves

Others

Therapeutic and surgical devices is the most popular device type

The report has provided a detailed breakup and analysis of the market based on the device type. This includes diagnostic and monitoring devices (electrocardiogram (ECG) remote cardiac monitoring, and others) and therapeutic and surgical devices (cardiac rhythm management (CRM) devices, catheter, stents, heart valves, and others). According to the report, therapeutic and surgical devices represent the largest segment.

The increasing number of surgical procedures and therapeutic interventions aimed at treating cardiovascular diseases is propelling the segment's growth. Moreover, therapeutic and surgical devices include implantable cardioverter defibrillators (ICDs), stents, pacemakers, catheters, heart valves, ventricular assist devices (VADs), etc. They aid in regulating heart rhythm, restoring blood flow, providing mechanical circulatory support, etc. Consequently, they are gaining extensive traction as less invasive alternatives to traditional open-heart surgeries, which is elevating the cardiovascular devices market demand. For example, in December 2023, Medtronic plc, one of the global leaders in healthcare technologies, announced the FDA approval of the PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF). In line with this, in June 2023, Magenta Medical launched a feasibility study for the world's smallest heart pump that reduces vascular access complications during heart surgery.

Breakup by Application:

Coronary Artery Disease (CAD)

Cardiac Arrhythmia

Heart Failure

Others

Coronary artery disease (CAD) dominates the cardiovascular devices market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes coronary artery disease (CAD), cardiac arrhythmia, heart failure, and others. According to the report, coronary artery disease (CAD) represented the largest market segmentation.

CAD devices used for treatment, diagnosis, and management of coronary artery disease condition are gaining traction across countries. Moreover, the widespread adoption of diagnostic devices, such as intravascular ultrasound (IVUS) devices, angiography systems, and computed tomography angiography (CTA) machines, as they help in assessing the severity of coronary artery blockages, is propelling the market. For example, in August 2022, Medtronic announced the launch of its novel drug-eluting coronary stent, the Onyx Frontier drug-eluting stent (DES), following CE Mark approval. Besides this, in January 2024, Cleerly, one of the companies working to create a new standard of care for the diagnosis of heart disease, introduced Cleerly ISCHEMIA, which recently received U.S. Food and Drug Administration (FDA) 510(k) medical device clearance. Cleerly ISCHEMIA analysis software is an automated machine learning-based decision support tool specifically designed for patients undergoing coronary computed tomography angiography (CCTA).

Breakup by End User:

Hospitals

Specialty Clinics

Others

Hospitals account for the majority of the overall market share

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, specialty clinics, and others. According to the report, hospitals represented the largest segment.

Hospitals are the primary end users of cardiovascular devices. They provide a wide range of cardiac services, such as treatment, diagnosis, and surgical procedures for cardiovascular diseases. Hospitals have cardiac catheterization labs and specialized cardiology departments equipped with advanced imaging systems and surgical suites, which is increasing the cardiovascular devices market's recent price. For instance, in January 2024, Sylvia Jones, the health minister of Ontario, announced the development of a new cardiac lab at St. Mary's General Hospital in Kitchener, Canada, to help cardiac patients. They require a comprehensive range of devices, such as implantable devices, diagnostic equipment, surgical instruments, monitoring systems, etc., which is driving the growth in this segmentation.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest market for cardiovascular devices.

The increasing prevalence of cardiovascular conditions, including stroke and peripheral artery disease, is propelling the regional market. For instance, as per the report published by the Heart and Stroke Foundation of Canada in February 2022, there were 750,000 patients diagnosed with heart failure. Moreover, favorable reimbursement policies and fast regulatory approvals are acting as significant growth-inducing factors. For example, in September 2023, CorVista Health announced the FDA approval of its non-invasive medical device system that is used for detecting the presence of cardiac disease. In line with this, in January 2024, Occlutech, a Swedish medical device company focused on structural heart disease, received the U.S. FDA approval for its ASD Occluder for the treatment of atrial septal defects (ASDs). Apart from this, as per the cardiovascular devices market statistics, the introduction of wireless ECG has allowed for real-time patient monitoring and diagnosis. This, in turn, will continue to stimulate the regional market in the coming years. For example, in February 2021, VivaLNK developed a wearable ECG monitoring solution designed to wirelessly capture ECG and heart rate during a six-minute walk test (6MWT).

Competitive Landscape:

The key players are investing significantly in R&D to develop innovative cardiovascular devices. They focus on improving device performance, durability, and patient outcomes. R&D efforts aim to introduce advanced technologies, such as minimally invasive procedures, remote monitoring systems, and personalized medicine approaches. Additionally, cardiovascular devices market companies are continuously launching new cardiovascular devices to expand their product portfolios. These launches often involve next-generation devices with improved features and enhanced capabilities. They are prioritizing addressing unmet clinical needs, such as novel therapies for specific cardiovascular conditions or devices that offer improved precision and ease of use. Besides this, collaborations and partnerships between key players, healthcare providers, and research institutions are common in the cardiovascular devices market. These collaborations foster innovation, facilitate knowledge exchange, and leverage collective expertise and resources to develop and commercialize new technologies and solutions.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

B. Braun Melsungen AG

Biotronik

Boston Scientific Corporation

Canon Medical Systems Corporation

Cardinal Health Inc.

Edwards Lifesciences Corporation

General Electric Company

LivaNova Plc

Medtronic Plc

Siemens Healthineers GmbH (Siemens AG)

Terumo Cardiovascular Systems Corporation (Terumo Corporation)

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Cardiovascular Devices Market Recent Developments:

May 2024: According to new one-year data presented at the annual meeting of the Society for Cardiovascular Angiography and Interventions (SCAI), a new biomimetic transcatheter aortic valve replacement (TAVR) system developed by Anteris Technologies can offer cardiologists with a new way to treat severe aortic stenosis (AS).

May 2024: According to the article published in the journal npj Fexible Electronics, a team of researchers from China presented a novel approach to use wearable sensors for assessing vascular age and cardiovascular diseases.

April 2024: The FAST TRACK CABG study, overseen by a team of researchers at the University of Galway, tested a new approach to the planning, guidance, and conducting of heart bypass surgery on patients for the first time.

January 2024: India Medtronic Private Limited announced a strategic collaboration with Cardiac Design Labs (CDL) to scale up, launch, and expand access to CDL's novel diagnostic technology, Padma Rhythms, an external loop recorder (ELR) patch designed for long-term and comprehensive heart monitoring and diagnosis.

Key Questions Answered in This Report

  • 1. What was the size of the global cardiovascular devices market in 2023?
  • 2. What is the expected growth rate of the global cardiovascular devices market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global cardiovascular devices market?
  • 4. What are the key factors driving the global cardiovascular devices market?
  • 5. What is the breakup of the global cardiovascular devices market based on the device type?
  • 6. What is the breakup of the global cardiovascular devices market based on the application?
  • 7. What is the breakup of the global cardiovascular devices market based on the end user?
  • 8. What are the key regions in the global cardiovascular devices market?
  • 9. Who are the key players/companies in the global cardiovascular devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiovascular Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device Type

  • 6.1 Diagnostic and Monitoring Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Electrocardiogram (ECG)
      • 6.1.2.2 Remote Cardiac Monitoring
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutic and Surgical Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Cardiac Rhythm Management (CRM) Devices
      • 6.2.2.2 Catheter
      • 6.2.2.3 Stents
      • 6.2.2.4 Heart Valves
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Coronary Artery Disease (CAD)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiac Arrhythmia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Heart Failure
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Biotronik
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Boston Scientific Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Canon Medical Systems Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Cardinal Health Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Edwards Lifesciences Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 General Electric Company
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 LivaNova PLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Medtronic PLC
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Siemens Healthineers GmbH (Siemens AG)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Terumo Cardiovascular Systems Corporation (Terumo Corporation)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Cardiovascular Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiovascular Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cardiovascular Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Cardiovascular Devices Market: Breakup by Device Type (in %), 2023
  • Figure 5: Global: Cardiovascular Devices Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Cardiovascular Devices Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Cardiovascular Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Cardiovascular Devices (Diagnostic and Monitoring Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Cardiovascular Devices (Diagnostic and Monitoring Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Cardiovascular Devices (Therapeutic and Surgical Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Cardiovascular Devices (Therapeutic and Surgical Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Cardiovascular Devices (Coronary Artery Disease-CAD) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Cardiovascular Devices (Coronary Artery Disease-CAD) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Cardiovascular Devices (Cardiac Arrhythmia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Cardiovascular Devices (Cardiac Arrhythmia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Cardiovascular Devices (Heart Failure) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Cardiovascular Devices (Heart Failure) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Cardiovascular Devices (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Cardiovascular Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Cardiovascular Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Cardiovascular Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Cardiovascular Devices (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Cardiovascular Devices (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Cardiovascular Devices (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Cardiovascular Devices (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Cardiovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Cardiovascular Devices Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Cardiovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Cardiovascular Devices Industry: SWOT Analysis
  • Figure 76: Global: Cardiovascular Devices Industry: Value Chain Analysis
  • Figure 77: Global: Cardiovascular Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cardiovascular Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cardiovascular Devices Market Forecast: Breakup by Device Type (in Million US$), 2024-2032
  • Table 3: Global: Cardiovascular Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Cardiovascular Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Cardiovascular Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Cardiovascular Devices Market: Competitive Structure
  • Table 7: Global: Cardiovascular Devices Market: Key Players